Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li C Cheung

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Gynecologic Oncology|June 14, 2017
Why does cervical cancer occur in a state-of-the-art screening program?Philip E Castle, Walter K Kinney, Li C Cheung, et al.
Annals of Internal Medicine|November 29, 2017
Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort StudyPhilip E Castle, Walter K Kinney, Xiaonan Xue, et al.
Preventive Medicine|December 10, 2017
Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-recordsRebecca Landy, Li C Cheung, Mark Schiffman, et al.
Journal of the National Cancer Institute|September 27, 2023
Artificial intelligence-based image analysis in clinical testing: lessons from cervical cancer screeningDidem Egemen, Rebecca B Perkins, Li C Cheung, et al.
Journal of the American Medical Informatics Association : JAMIA|February 15, 2022
Inaccuracies in electronic health records smoking data and a potential approach to address resulting underestimation in determining lung cancer screening eligibilityPolina V Kukhareva, Tanner J Caverly, Haojia Li, et al.
Journal of Lower Genital Tract Disease|January 10, 2025
Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring GuidelinesL Stewart Massad, Megan A Clarke, Rebecca B Perkins, et al.
Cancer Cytopathology|July 22, 2014
The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical managementJulia C Gage, Hormuzd A Katki, Mark Schiffman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 17, 2026
Long-Term Prospective Cohort Study of Cervical Cancer Screening Using Triage of Women who Are Human Papillomavirus-Positive With Dual Stain and Human Papillomavirus GenotypingNicolas Wentzensen, Didem Egemen, Megan A Clarke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 18, 2021
The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline CharacteristicsJulia C Gage, Tina Raine-Bennett, Mark Schiffman, et al.
Journal of Lower Genital Tract Disease|April 4, 2020
A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus GuidelinesMaria Demarco, Didem Egemen, Tina R Raine-Bennett, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Gynecologic Oncology|June 14, 2017
Why does cervical cancer occur in a state-of-the-art screening program?Philip E Castle, Walter K Kinney, Li C Cheung, et al.
Annals of Internal Medicine|November 29, 2017
Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort StudyPhilip E Castle, Walter K Kinney, Xiaonan Xue, et al.
Preventive Medicine|December 10, 2017
Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-recordsRebecca Landy, Li C Cheung, Mark Schiffman, et al.
Journal of the National Cancer Institute|September 27, 2023
Artificial intelligence-based image analysis in clinical testing: lessons from cervical cancer screeningDidem Egemen, Rebecca B Perkins, Li C Cheung, et al.
Journal of the American Medical Informatics Association : JAMIA|February 15, 2022
Inaccuracies in electronic health records smoking data and a potential approach to address resulting underestimation in determining lung cancer screening eligibilityPolina V Kukhareva, Tanner J Caverly, Haojia Li, et al.
Journal of Lower Genital Tract Disease|January 10, 2025
Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring GuidelinesL Stewart Massad, Megan A Clarke, Rebecca B Perkins, et al.
Cancer Cytopathology|July 22, 2014
The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical managementJulia C Gage, Hormuzd A Katki, Mark Schiffman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 17, 2026
Long-Term Prospective Cohort Study of Cervical Cancer Screening Using Triage of Women who Are Human Papillomavirus-Positive With Dual Stain and Human Papillomavirus GenotypingNicolas Wentzensen, Didem Egemen, Megan A Clarke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 18, 2021
The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline CharacteristicsJulia C Gage, Tina Raine-Bennett, Mark Schiffman, et al.
Journal of Lower Genital Tract Disease|April 4, 2020
A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus GuidelinesMaria Demarco, Didem Egemen, Tina R Raine-Bennett, et al.
Pageof 10